Recombinant Absent In Melanoma 1 (AIM1)
-
Catalog numberRPU53662-100ug
-
PricePlease ask
-
Size100ug
-
-
Estimated Turnaround Time6-11 business days
-
Gene NameNA
-
Alternative NamesST4; CRYBG1; Suppression Of Tumorigenicity 4; Beta-Gamma Crystallin Domain Containing 1
-
SourceE.coli
-
Purity≥ 95%
-
ApplicationPositive Control; Immunogen; SDS-PAGE; WB.
-
Shipping ConditionsIce packs
-
Storage conditionsShort term: -20°C; Long term: -80°C. Minimize freeze and thaw cycles.
-
Shelf life1 year
-
RestrictionFor research use only. Not for diagnostic procedures.
-
Additional sourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Gene symbolCRYBG1
-
Short nameRecombinant Absent In Melanoma 1 (AIM1)
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. Biomatik advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
SpeciesHomo sapiens (Human)
-
Alternative nameRec. Absent In Melanoma 1 (AIM1)
-
Alternative techniquerec
-
Gene info
-
Identity
-
Gene
-
Long gene namecrystallin beta-gamma domain containing 1
-
Synonyms gene
-
Synonyms gene name
- suppression of tumorigenicity 4 (malignant melanoma)
- absent in melanoma 1
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1997-06-12
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Beta-gamma crystallin domain containing
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
-
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery